Issue 2/2001
Content (10 Articles)
Fas ligand expression in BRCA1-associated hereditary breast carcinoma clearly differs from that in sporadic breast carcinoma
Yasuhiro Ito, Shinzaburo Noguchi, Tsutomu Takeda, Nariaki Matsuura
Metastatic bone pain palliation with 89‐Sr and 186‐Re‐HEDP in breast cancer patients
Rosa Sciuto, Anna Festa, Rosella Pasqualoni, Alessandro Semprebene, Sandra Rea, Serenella Bergomi, Carlo L. Maini
Oncostatin M–induced growth inhibition and morphological changes of MDA‐MB231 breast cancer cells are abolished by blocking the MEK/ERK signaling pathway
Cong Li, Thomas E. Ahlborn, Fredric B. Kraemer, Jingwen Liu
Are medical oncologists biased in their treatment of the large woman with breast cancer?
Yolanda Madarnas, Carol A. Sawka, Edmée Franssen, Georg A. Bjarnason
Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women
Patrizia Querzoli, Giuseppe Albonico, Maria Grazia di Iasio, Stefano Ferretti, Rosa Rinaldi, Anna Cariello, Massimo Pedriali, Maurizio Matteuzzi, Iva Maestri, Italo Nenci
Generation of reactive oxygen species by xanthine derivatives in MDA‐MB‐231 human breast cancer cells
T.L. Crumpton, F.J. Seidler, T.A. Slotkin
Methyl‐substituted diindolylmethanes as inhibitors of estrogen‐induced growth of T47D cells and mammary tumors in rats
Andrew McDougal, Mona Sethi Gupta, Derek Morrow, Kavita Ramamoorthy, Jeong‐Eun Lee, Stephen H. Safe
Clinical significance of vascular endothelial growth factor‐C (VEGF‐C) in breast cancer
Junko Kinoshita, Kaoru Kitamura, Akira Kabashima, Hiroshi Saeki, Shinji Tanaka, Keizo Sugimachi
Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors
Kazuyuki Yazawa, Minoru Fujimori, Toshiyuki Nakamura, Takayuki Sasaki, Jun Amano, Yasunobu Kano, Shun’ichiro Taniguchi